Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 495

1.

The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake.

Campbell NRC, He FJ, Tan M, Cappuccio FP, Neal B, Woodward M, Cogswell ME, McLean R, Arcand J, MacGregor G, Whelton P, Jula A, L'Abbe MR, Cobb LK, Lackland DT.

J Clin Hypertens (Greenwich). 2019 May 14. doi: 10.1111/jch.13551. [Epub ahead of print]

2.

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.

Schlackow I, Kent S, Herrington W, Emberson J, Haynes R, Reith C, Collins R, Landray MJ, Gray A, Baigent C, Mihaylova B; SHARP Collaborative Group.

Kidney Int. 2019 Mar 12. pii: S0085-2538(19)30171-1. doi: 10.1016/j.kint.2019.01.028. [Epub ahead of print]

PMID:
31005271
3.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators.

N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMoa1811744. [Epub ahead of print]

PMID:
30990260
4.

Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program.

Figtree GA, Rådholm K, Barrett TD, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Matthews DR, Shaw W, Neal B.

Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040057. [Epub ahead of print]

PMID:
30882240
5.

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.

Matthews DR, Li Q, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Desai M, Hiatt WR, Nehler M, Fabbrini E, Kavalam M, Lee M, Neal B.

Diabetologia. 2019 Jun;62(6):926-938. doi: 10.1007/s00125-019-4839-8. Epub 2019 Mar 12.

6.

Sources of Dietary Salt in North and South India Estimated from 24 Hour Dietary Recall.

Johnson C, Santos JA, Sparks E, Raj TS, Mohan S, Garg V, Rogers K, Maulik PK, Prabhakaran D, Neal B, Webster J.

Nutrients. 2019 Feb 1;11(2). pii: E318. doi: 10.3390/nu11020318.

7.

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis.

Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine MJ, Heerspink HL, Wong MG, Ninomiya T, Wada T, Perkovic V.

Diabetes Obes Metab. 2019 May;21(5):1237-1250. doi: 10.1111/dom.13648. Epub 2019 Mar 4.

PMID:
30697905
8.

Estimating the health benefits and cost-savings of a cap on the size of single serve sugar-sweetened beverages.

Cleghorn C, Blakely T, Mhurchu CN, Wilson N, Neal B, Eyles H.

Prev Med. 2019 Mar;120:150-156. doi: 10.1016/j.ypmed.2019.01.009. Epub 2019 Jan 18.

PMID:
30660706
9.

Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".

Figtree GA, Rådholm K, Neal B.

Circulation. 2019 Jan 15;139(3):418-419. doi: 10.1161/CIRCULATIONAHA.118.038477. No abstract available.

PMID:
30640545
10.

Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial.

Jardine MJ, Li N, Ninomiya T, Feng X, Zhang J, Shi J, Zhang Y, Zhang R, Zhang J, Hao J, Perkovic V, Heerspink HL, Wu Y, Yan LL, Neal B.

J Ren Nutr. 2018 Dec 24. pii: S1051-2276(18)30247-4. doi: 10.1053/j.jrn.2018.10.009. [Epub ahead of print]

PMID:
30591358
11.

Canagliflozin and Stroke in Type 2 Diabetes Mellitus.

Zhou Z, Lindley RI, Rådholm K, Jenkins B, Watson J, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Shaw W, Oh R, Desai M, Matthews DR, Neal B.

Stroke. 2019 Feb;50(2):396-404. doi: 10.1161/STROKEAHA.118.023009.

12.

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.

Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.

PMID:
30571562
13.

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A; Blood Pressure Lowering Treatment Trialists’ Collaboration.

J Hypertens. 2019 Jan;37(1):16-23. doi: 10.1097/HJH.0000000000001994.

PMID:
30499920
15.

Evaluation of a call center to assess post-discharge maternal and early neonatal outcomes of facility-based childbirth in Uttar Pradesh, India.

Gass JD Jr, Semrau K, Sana F, Mankar A, Singh VP, Fisher-Bowman J, Neal BJ, Tuller DE, Kumar B, Lipsitz S, Sharma N, Kodkany B, Kumar V, Gawande A, Hirschhorn LR.

PLoS One. 2018 Nov 27;13(11):e0207987. doi: 10.1371/journal.pone.0207987. eCollection 2018.

16.

Can front-of-pack labels influence portion size judgements for unhealthy foods? - CORRIGENDUM.

Talati Z, Pettigrew S, Kelly B, Ball K, Neal B, Dixon H, Shilton T, Miller C.

Public Health Nutr. 2019 Mar;22(3):571-572. doi: 10.1017/S1368980018003099. Epub 2018 Oct 31. No abstract available.

17.

A randomized trial assessing the effects of health claims on choice of foods in the presence of front-of-pack labels.

Talati Z, Norman R, Kelly B, Dixon H, Neal B, Miller C, Pettigrew S.

Am J Clin Nutr. 2018 Dec 1;108(6):1275-1282. doi: 10.1093/ajcn/nqy248.

PMID:
30351342
18.

Spot urine samples compared with 24-h urine samples for estimating changes in urinary sodium and potassium excretion in the China Salt Substitute and Stroke Study.

Huang L, Woodward M, Stepien S, Tian M, Yin X, Hao Z, Li Z, Sun J, Yu Y, Zhou B, Zhao Y, Wu Y, Neal B.

Int J Epidemiol. 2018 Dec 1;47(6):1811-1820. doi: 10.1093/ije/dyy206.

PMID:
30307504
19.

Risk factors for patellofemoral pain: a systematic review and meta-analysis.

Neal BS, Lack SD, Lankhorst NE, Raye A, Morrissey D, van Middelkoop M.

Br J Sports Med. 2019 Mar;53(5):270-281. doi: 10.1136/bjsports-2017-098890. Epub 2018 Sep 21.

PMID:
30242107
20.

Endoscopic Resection Followed by Proton Therapy With Pencil Beam Scanning for Skull Base Tumors.

Leeman JE, Lee NY, Zhou Y, Neal B, Sine K, Tabar V, Cohen MA.

Laryngoscope. 2019 Jun;129(6):1313-1317. doi: 10.1002/lary.27512. Epub 2018 Sep 12.

PMID:
30208224

Supplemental Content

Loading ...
Support Center